M. Alam

Interference by Human Anti-mouse Antibodies in Immunoassays: Falsely Elevated Cardiac Troponins Leading to Negative Coronary Angiograms

M. Alam, Surachit Kumar, Ibrahim Sbietan, 2015 .

Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy in ischemic vs nonischemic cardiomyopathy patients.

S. Saba, D. Schwartzman, J. Gorcsan, 2014, Heart rhythm.

Influence of QRS duration on outcome of death or appropriate defibrillator therapy by strategy of left ventricular lead placement in cardiac resynchronization therapy recipients

S. Saba, D. Schwartzman, J. Gorcsan, 2014, Journal of Interventional Cardiac Electrophysiology.

Effect of echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy on mortality and risk of defibrillator therapy for ventricular arrhythmias in heart failure patients (from the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region [STARTER] tr

S. Saba, D. Schwartzman, J. Gorcsan, 2014, The American journal of cardiology.

Battery longevity from cardiac resynchronization therapy defibrillators: differences between manufacturers and discrepancies with published product performance reports

S. Saba, E. Adelstein, M. Alam, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Developing a panel of biomarkers and miRNA in patients with myocardial infarction for early intervention strategies of heart failure in West Virginian population

J. Shapiro, N. Puri, K. Sodhi, 2018, PloS one.

Frequency and characteristics of skin cancers diagnosed at Ayub Medical College, Abbottabad Pakistan from 1995-2003.

S. Shah, Ayesha Ahmed, M. Alam, 2007, Journal of Ayub Medical College, Abbottabad : JAMC.

Pacing and resynchronization therapy Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators

S. Saba, E. Adelstein, M. Alam, 2014 .

Outcomes of Sprint Fidelis and Riata lead extraction: Data from 2 high-volume centers.

D. Delurgio, J. Langberg, S. Saba, 2015, Heart Rhythm.

A Fatal Case of Nafcillin-Induced Hepatotoxicity: A Case Report and the Literature Review

M. Sathaiah, M. Alam, Amin Kadoura, 2012, Case reports in medicine.

Patient Outcomes According to Adherence to Treatment Guidelines for Rhythm Control of Atrial Fibrillation

S. Saba, G. Leef, M. Alam, 2015, Journal of the American Heart Association.

Mortality risk of long-term amiodarone therapy for atrial fibrillation patients without structural heart disease.

S. Saba, G. Leef, M. Alam, 2015, Cardiology journal.

Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.

S. Saba, G. Leef, M. Alam, 2016, Journal of cardiology.

Risk of Stroke and Death in Atrial Fibrillation by Type of Anticoagulation: A Propensity‐Matched Analysis

S. Saba, A. Althouse, G. Leef, 2015, Pacing and clinical electrophysiology : PACE.

Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.

Samir Saba, S. Saba, M. Alam, 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Antithrombotic Therapy in Nonvalvular Atrial Fibrillation: Consensus and Challenges

S. Saba, C. Lavie, T. Paul, 2018, The American journal of the medical sciences.